Back to top

If you wish to go to ZacksFunds.com, click OK. If you do not, click Cancel.

Biotechnology Ultra Sector Pro F: (MF: BIPSX)

(MF) As of Nov 20, 2014 06:05 PM ET

 Add to portfolio

$59.41 USD

-0.53 (-0.88%)

Zacks MF Rank : 1 - Strong Buy [?] 1        

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

General Information as of Oct 31, 2014

% Yield 0.00
% SEC Yield NA
% YTD Return (as of Oct 31, 2014) 48.64
Objective Sector - Health
Peer HL LG

Zacks Premium Research for BIPSX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank [?] Rank Change Trend Strong Buy 1
MF Research Report

( = Change in last 30 days)

Zacks Mutual Fund #1 Ranked Funds

View the Zacks Mutual Fund Rank Guide

Portfolio Statistics

%Unrealized Gain YTD 23.68
Net Assets (Mil $) 10/31/2014 19.83
%Turnover 10/31/2014 47.00

Allocation

% of Portfolio
Large Growth 70.65
Large Value 0.00
Small Growth 0.00
Small Value 0.00
Foreign Stock 0.00
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 0.00
Foreign Bond 0.00
High Yield Bond 0.00

Sector / Country Weightings

As of 10/31/2014 % of Portfolio
Other 41.21
Health 30.67
Services 16.98
Industrial Cyclical 8.36
Technology 2.78

Portfolio Holdings

Top Equity Holdings
(As of 7/31/2014)
% of Portfolio Value (Mil$)
GILEAD SCIENCES INC 14.84 68.90
AMGEN INC 10.20 47.35
ABBVIE INC 8.78 40.77
BIOGEN IDEC INC 8.36 38.78
CELGENE CORP 7.37 34.23
ALEXION PHARMACEUTICALS I 3.34 15.51
REGENERON PHARMACEUTICALS 2.69 12.50
VERTEX PHARMACEUTICALS IN 2.22 10.31
ILLUMINA INC 2.18 10.12

Stock Holding % of Net Assets

As Of 7/31/2014
Total Issues 27
Avg. P/E 42.54
Avg. P/Book 6.09
Avg. EPS Growth 15.8
Avg. Market Value (Mil $) 78,514

Risk

3 Year 5 Year 10 Year
Beta 1.72 1.29 1.06
Alpha 32.09 22.61 15.69
R Squared 0.35 0.42 0.30
Std. Dev. 26.35 26.34 28.62
Sharpe 3.02 1.92 2.00